HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, E. J. Articles by Huh, K. B. Search for Related Content PubMed Articles by Lee, E. J. Articles by Huh, K. B.

Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog)

Lee EJ, Kim KR, Lim SK, Lee HC, Kim DI, Kim SH, Huh KB. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). Eur J Endocrinol 1994;131: 109–12. ISSN 0804–4643

We present a 55-year-old female with a thyrotropin (TSH)-secreting pituitary adenoma who had been treated with somatostatin analog octreotide acetate (SMS 201–995) for 4 months. Subcutaneous injection of 100 µg octreotide acetate twice daily resulted in significant reduction of the TSH, thyroid hormone, and tumor size. During the treatment, there was no evidence of any side effects. We may conclude that octreotide acetate administration is an effective treatment in patients with TSHsecreting pituitary adenoma for suppressing TSH hypersecretion and reducing the size of the tumor.

Eun Jig Lee, Division of Endocrinology, Department of Internal Medicine, Yong Dong Severance Hospital, Youngdong PO Box 1217, Seoul 135-270, Korea

This article has been cited by other articles:

				E. J. Lee and J L. Jameson Gene therapy of pituitary diseases J. Endocrinol., June 1, 2005; 185(3): 353 - 362. [Abstract] [Full Text] [PDF]